Amicus Therapeutics, Inc. (FOLD)

14.22 +0.02 (+0.11%) USD  |  NASDAQ  |  Dec 24, 10:51
More

Amicus Therapeutics SG&A Expense (TTM): 353.07M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for FOLD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
BioMarin Pharmaceutical, Inc. 973.41M
CorMedix, Inc. 75.56M
ANI Pharmaceuticals, Inc. 304.67M
Gilead Sciences, Inc. 5.886B
ACADIA Pharmaceuticals, Inc. 523.36M